13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
|
SANOFI SA INHABER EO 2 |
920657 |
Xetra |
91,000 |
25.06.24 16:39:59 |
+0,210 |
+0,23% |
90,940 |
90,990 |
90,870 |
90,790 |
|
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
986,000 |
25.06.24 08:13:49 |
+1,400 |
+0,14% |
1.005,500 |
1.011,500 |
986,000 |
984,600 |